Literature DB >> 26770907

A Rare Consequence of Chronic Graft Versus Host Disease - Peyronie's Disease.

Natasha A Jain1, Krishnan Venkatesan2, Prathima Anandi1, Sawa Ito1, Dhruv Kumar3, Kit Lu1, Minoo Battiwalla1, A John Barrett1.   

Abstract

Chronic graft versus host disease (GvHD) after allogeneic stem cell transplantation (SCT) may involve any organ system, but male genital involvement is rare. Peyronie's Disease (PD) is an acquired, localized fibrotic disorder of the tunica albuginea, which leads to penile deformity, pain, and eventually to erectile dysfunction. We report the case of a 52 year old African American male with Acute Myeloid Leukemia who underwent human leucocyte antigen (HLA) matched sibling allogeneic peripheral blood SCT. His post transplant course was complicated by development of acute and multi-organ chronic GvHD requiring prolonged immunosuppression. He developed progressive dorsal curvature of the penis with erections within 1 year of ultra low dose interleukin -2 (IL2) treatment for his chronic GvHD but concealed symptoms for several months. Color Doppler Duplex ultrasound evaluation of the erect penis revealed a 75-degree curvature and appropriate hemodynamic response to prostaglandin injection. He underwent successful incision and grafting of the penile plaque. There is no significant residual curvature and is now able to engage in intercourse. A strong temporal association between GVHD (or its treatment) and Peyronie's is documented here. Awareness of the possible link between PD and chronic GVHD is required in this era of rapid growth in numbers of SCT.

Entities:  

Keywords:  Chronic graft versus host disease; Peyronie’s disease

Year:  2015        PMID: 26770907      PMCID: PMC4710351          DOI: 10.21767/2254-6081.100018

Source DB:  PubMed          Journal:  Arch Cancer Res        ISSN: 2254-6081


  8 in total

1.  François de la Peyronie and the disease named after him.

Authors:  E W Hauck; W Weidner
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

2.  Validity and reliability of a smartphone application for the assessment of penile deformity in Peyronie's disease.

Authors:  Ryan S Hsi; James M Hotaling; Andrea L Hartzler; Sarah K Holt; Thomas J Walsh
Journal:  J Sex Med       Date:  2013-04-03       Impact factor: 3.802

3.  Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  M Kami; Y Kanda; M Sasaki; N Takeda; Y Tanaka; T Saito; S Ogawa; H Honda; S Chiba; K Mitani; H Hirai; Y Yazaki
Journal:  Bone Marrow Transplant       Date:  1998-04       Impact factor: 5.483

4.  An analysis of the natural history of Peyronie's disease.

Authors:  John P Mulhall; Jonathan Schiff; Patricia Guhring
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

Review 5.  Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Authors:  Dana Shanis; Melissa Merideth; Tajana Klepac Pulanic; Bipin N Savani; Minoo Battiwalla; Pamela Stratton
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

6.  Peyronie's disease as a complication of chronic graft versus host disease.

Authors:  A P Grigg; C Underhill; J Russell; G Sale
Journal:  Hematology       Date:  2002-06       Impact factor: 2.269

7.  Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.

Authors:  Simon M Mueller; Peter Haeusermann; Alicia Rovó; Joerg P Halter; Jakob Passweg; Peter Itin; André Tichelli
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-17       Impact factor: 5.742

Review 8.  The non-surgical treatment of peyronie disease: 2013 update.

Authors:  Eric James Shaw; Gregory Clyde Mitchell; Ronny B Tan; Premsant Sangkum; Wayne John G Hellstrom
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

  8 in total
  4 in total

Review 1.  Clinical management of genital chronic GvHD.

Authors:  B K Hamilton; O Goje; B N Savani; N S Majhail; P Stratton
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

2.  Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Authors:  Rachel Phelan; Annie Im; Rebecca L Hunter; Yoshihiro Inamoto; Maria Teresa Lupo-Stanghellini; Alicia Rovo; Sherif M Badawy; Linda Burns; Hesham Eissa; Hemant S Murthy; Pinki Prasad; Akshay Sharma; Elizabeth Suelzer; Vaibhav Agrawal; Mahmoud Aljurf; Karen Baker; Grzegorz W Basak; David Buchbinder; Zachariah DeFilipp; Lana Desnica Grkovic; Ajoy Dias; Hermann Einsele; Michael L Eisenberg; Narendranath Epperla; Nosha Farhadfar; Arthur Flatau; Robert Peter Gale; Hildegard Greinix; Betty K Hamilton; Shahrukh Hashmi; Peiman Hematti; Kareem Jamani; Dipnarine Maharaj; John Murray; Seema Naik; Sunita Nathan; Steven Pavletic; Zinaida Peric; Drazen Pulanic; Richard Ross; Andrea Salonia; Isabel Sanchez-Ortega; Bipin N Savani; Tal Schechter; Ami J Shah; Stephanie M Smith; John A Snowden; Amir Steinberg; Douglas Tremblay; Sarah C Vij; Lauren Walker; Daniel Wolff; Jean A Yared; Hélène Schoemans; André Tichelli
Journal:  Transplant Cell Ther       Date:  2021-10-29

3.  The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review.

Authors:  Alessander Leyendecker; Carla Cristina Gomes Pinheiro; Mariane Tami Amano; Daniela Franco Bueno
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

4.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.